Metabolism of methylstenbolone studied with human liver microsomes and the uPA⁺/⁺-SCID chimeric mouse model.

Anti-doping laboratories need to be aware of evolutions on the steroid market and elucidate steroid metabolism to identify markers of misuse. Owing to ethical considerations, in vivo and in vitro models are preferred to human excretion for nonpharmaceutical grade substances. In this study the chimeric mouse model and human liver microsomes (HLM) were used to elucidate the phase I metabolism of a new steroid product containing, according to the label, methylstenbolone. Analysis revealed the presence of both methylstenbolone and methasterone, a structurally closely related steroid. Via HPLC fraction collection, methylstenbolone was isolated and studied with both models. Using HLM, 10 mono-hydroxylated derivatives (U1-U10) and a still unidentified derivative of methylstenbolone (U13) were detected. In chimeric mouse urine only di-hydroxylated metabolites (U11-U12) were identified. Although closely related, neither methasterone nor its metabolites were detected after administration of isolated methylstenbolone. Administration of the steroid product resulted mainly in the detection of methasterone metabolites, which were similar to those already described in the literature. Methylstenbolone metabolites previously described were not detected. A GC-MS/MS multiple reaction monitoring method was developed to detect methylstenbolone misuse. In one out of three samples, previously tested positive for methasterone, methylstenbolone and U13 were additionally detected, indicating the applicability of the method.

[1]  B. Garrido,et al.  Detection of designer steroid methylstenbolone in “nutritional supplement” using gas chromatography and tandem mass spectrometry: Elucidation of its urinary metabolites , 2013, Steroids.

[2]  G. Leroux-Roels,et al.  Metabolic studies with promagnon, methylclostebol and methasterone in the uPA+/+-SCID chimeric mice , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  P. Teale,et al.  Comparative in vitro metabolism of the ‘designer’ steroid estra-4,9-diene-3,17-dione between the equine, canine and human: Identification of target metabolites for use in sports doping control , 2010, Steroids.

[4]  P. Teale,et al.  The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine , 2010, Steroids.

[5]  P. Van Eenoo,et al.  The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione , 2009, Drug Metabolism and Disposition.

[6]  Ó. Pozo,et al.  Steroid metabolism in chimeric mice with humanized liver. , 2009, Drug testing and analysis.

[7]  Ó. Pozo,et al.  Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism. , 2009, Drug testing and analysis.

[8]  Ó. Pozo,et al.  uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study. , 2009, Clinical chemistry.

[9]  M. Koupparis,et al.  Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  J. Ahmad,et al.  Severe Cholestasis and Renal Failure Associated with the Use of the Designer Steroid Superdrol™ (Methasteron™): A Case Report and Literature Review , 2009, Digestive Diseases and Sciences.

[11]  V. Balan,et al.  Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement. , 2009, Journal of clinical gastroenterology.

[12]  D. Poirier,et al.  Identification of drostanolone and 17-methyldrostanolone metabolites produced by cryopreserved human hepatocytes , 2009, Steroids.

[13]  J. V. Sancho,et al.  Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation. , 2008, Rapid communications in mass spectrometry : RCM.

[14]  M. Thevis,et al.  Nutritional supplements cross-contaminated and faked with doping substances. , 2008, Journal of mass spectrometry : JMS.

[15]  Ó. Pozo,et al.  Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry. , 2008, Analytical chemistry.

[16]  L. Jia,et al.  The conduct of drug metabolism studies considered good practice (II): in vitro experiments. , 2007, Current drug metabolism.

[17]  A. Nadir,et al.  Cholestatic Jaundice and IgA Nephropathy Induced by OTC Muscle Building Agent Superdrol , 2006, The American Journal of Gastroenterology.

[18]  P. Eenoo,et al.  Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  P. Van Eenoo,et al.  Nutritional supplements: prevalence of use and contamination with doping agents , 2006, Nutrition Research Reviews.

[20]  N. Helsby,et al.  Can in vitro drug metabolism studies with human tissue replace in vivo animal studies? , 2006, Environmental toxicology and pharmacology.

[21]  Y. Aubin,et al.  Discovery, biosynthesis, and structure elucidation of new metabolites of norandrostenedione using in vitro systems , 2005, Steroids.

[22]  T. Roskams,et al.  Morphological and biochemical characterization of a human liver in a uPA‐SCID mouse chimera , 2005, Hepatology.

[23]  D. B. Gower,et al.  Anabolic steroids in sport: biochemical, clinical and analytical perspectives , 2003, Annals of clinical biochemistry.

[24]  Jos H Beijnen,et al.  An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. , 2003, Toxicology and applied pharmacology.

[25]  R. Massé,et al.  Studies on anabolic steroids—11. 18-hydroxylated metabolites of mesterolone, methenolone and stenbolone: New steroids isolated from human urine , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  R. Massé,et al.  Studies on anabolic steroids—6. Identification of urinary metabolites of stenbolone acetate (17β-acetoxy-2-methyl-5α-androst-1-en-3-one) in human by gas chromatography/mass spectrometry , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  R. Massé,et al.  Studies on anabolic steroids—4. Identification of new urinary metabolites of methenolone acetate (primobolan®) in human by gas chromatography/mass spectrometry , 1990, The Journal of Steroid Biochemistry and Molecular Biology.